565
Views
73
CrossRef citations to date
0
Altmetric
Original

Quality of Life Among Heroin Users on Buprenorphine versus Methadone Maintenance

, M.D., Ph.D. & , M.D., Ph.D.
Pages 631-642 | Published online: 07 Jul 2009

REFERENCES

  • Verrando R, Robaeys G, Mathei C, Buntinx F. Methadone and buprenorphine maintenance therapies for patients with hepatitis C virus infected after intravenous drug use. Acta Gastroenterol Belg 2005; 68:81–85.
  • White JM, Lopatko OV. Opioid maintenance: A comparative review of pharmacological strategies. Expert Opin Pharmacother 2007; 8:1–11.
  • Lintzeris N, Ritter A, Panjari M, Clark N, Kutin J, Bammer G. Implementing buprenorphine treatment in community settings in Australia: Experiences from the buprenorphine implementation Trial. Am J Addict 2004; 13(Suppl 1):S29–41.
  • Barnett PG, Rodgers JH, Bloch DA. A meta-analysis comparing buprenorphine to methadone for treatment of opiate dependence. Addict 2001; 96:683–690.
  • Gonzalez G, Oliveto A, Kosten TR. Combating opiate dependence: A comparison among the available pharmacological options. Expert Opin Pharmacother 2004; 5:713–725.
  • Schottenfeld RS, Pakes JR, Kosten TR. Prognostic factors in buprenorphine- versus methadone-maintained patients. J Nerv Ment Dis 1998; 186:35–43.
  • Walsh SL, June HL, Schuh KJ, Preston KL, Bigelow GE, Stitzer ML. Effects of buprenorphine and methadone in methadone-maintained subjects. Psychopharmacol 1995; 119:268–276.
  • Mattick RP, Kimber J, Breen C, Davoli M. Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane Database Syst Rev 2004; CD002207.
  • Smith KW, Larson MJ. Quality of life assessments by adult substance abusers receiving publicly funded treatment in Massachusetts. Am J Drug Alcohol Abuse 2003; 29:323–335.
  • Giacomuzzi SM, Ertl M, Kemmler G, Riemer Y, Vigl A. Sublingual buprenorphine and methadone maintenance treatment: A three-year follow-up of quality of life assessment. Scientific World Journal 2005; 5:452–468.
  • Amato L, Davoli M, Perucci CA, Ferri M, Faggiano F, Mattick RP. An overview of systematic reviews of the effectiveness of opiate maintenance therapies: Available evidence to inform clinical practice and research. J Subst Abuse Treat 2005; 28:321–329.
  • Giacomuzzi S, Kemmler G, Ertl M, Riemer Y. Opioid addicts at admission vs. slow-release oral morphine, methadone, and sublingual buprenorphine maintenance treatment participants. Subst Use Misuse 2006; 41:223–244.
  • Ponizovsky AM, Grinshpoon A, Margolis A, Cohen R, Rosca P. Well-being, psychosocial factors, and side-effects among heroin-dependent inpatients after detoxification using buprenorphine versus clonidine. Addict Behav 200; 31:2002–2013.
  • Endicott J, Nee J, Harrison W, Blumenthal R. Quality of life enjoyment and satisfaction questionnaire: A new measure. Psychopharmacol Bull 1993; 29:321–326.
  • Rapaport MH, Clary C, Fayyad R, Endicott J. Quality-of-life impairment in depressive and anxiety disorders. Am J Psychiatry 2005; 162:1171–1178.
  • Ritsner M, Modai I, Endicott J, Rivkin O, Nechamkin Y, Barak P, Goldin V, Ponizovsky A. Differences in quality of life domains and psychopathologic and psychosocial factors in psychiatric patients. J Clin Psychiatry 2000; 61:880–889.
  • Sunderwirth SG, Milkman H. Behavioral and neurochemical commonalities in addiction. Cont Fam Ther 1991; 13:421–433.
  • Stimmel B, Kreek MJ. Neurobiology of addictive behaviors and its relationship to methadone maintenance. Mt Sinai J Med 2000; 67:375–380.
  • Bruera E, Sweeney C. Methadone use in cancer patients with pain: A review. J Palliat Med 2002; 5:127–138.
  • Ausubel DP. Methadone maintenance treatment: The other side of the coin. Int J Addict 1983; 18:851–862.
  • Jasinski DR, Preston KL. Comparison of intravenously administered methadone, morphine and heroin. Drug Alcohol Depend 1986; 17:301–310.
  • Zissi A, Barry MM, Cochrane R. A mediational model of quality of life for individuals with severe mental health problems. Psychol Med 1998; 28:1221–1230.
  • Comer SD, Sullivan MA, Walker EA. Comparison of intravenous buprenorphine and methadone self-administration by recently detoxified heroin-dependent individuals. J Pharmacol Exp Ther 2005; 315:1320–1330.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.